Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leptin and cardiovascular diseases.

Jian-Dong Luo1, Gen-Shui Zhang, Min-Sheng Chen

  • 1Department of Pharmacology, Guangzhou Medical College, Guangzhou, China. jiandong-luo@hotmail.com

Drug News & Perspectives
|December 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of stimulus types and valence on the affective memory performance of adults with anxiety.

Heliyon·2023
Same author

Flexural Strengthening of Large-Scale RC Beams with Nonprestressed and Prestressed CFRP Using Different Anchorages.

Polymers·2022
Same author

Effect of stimuli type on affective memory of patients with different severities of cognitive impairment.

Aging & mental health·2022
Same author

RNA sequencing reveals novel LncRNA/mRNAs co-expression network associated with puerarin-mediated inhibition of cardiac hypertrophy in mice.

PeerJ·2022
Same author

Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Catenin Degradation in Type 1 Diabetic Mice.

Diabetes·2022
Same author

Afterload-related cardiac performance identifies cardiac impairment and associates with outcome in patients with septic shock: a retrospective cohort study.

Journal of intensive care·2021

Leptin, a hormone linked to obesity, may significantly contribute to cardiovascular disease (CVD) through various mechanisms. Understanding leptin resistance could offer new treatments for obesity-related CVD.

Area of Science:

  • Endocrinology
  • Cardiovascular Science
  • Metabolic Research

Background:

  • Obesity is a major risk factor for cardiovascular disease (CVD), but the precise mechanisms remain unclear.
  • Leptin, a hormone regulating appetite and metabolism, is increasingly implicated in obesity-related CVD.
  • Evidence suggests leptin influences pathways contributing to hypertension, endothelial dysfunction, and atherosclerosis.

Purpose of the Study:

  • To elucidate the role of leptin in the development of cardiovascular disease in obesity.
  • To explore the mechanisms by which leptin may promote CVD.
  • To identify potential therapeutic targets related to leptin resistance for managing obesity-associated CVD.

Main Methods:

  • Review of existing animal and human studies on leptin's physiological effects.

Related Experiment Videos

  • Analysis of leptin's impact on sympathetic nerve activity, oxidative stress, and platelet function.
  • Examination of leptin's contribution to hypertension, endothelial dysfunction, and atherosclerosis.

    • Main Results:

    • Leptin modulates appetite and metabolism, but also increases sympathetic nerve activity.
    • Leptin stimulates reactive oxygen species generation and upregulates endothelin-1 production.
    • Leptin potentiates platelet aggregation, potentially contributing to atherosclerosis and hypertension.

    Conclusions:

    • Leptin plays a multifaceted role in promoting cardiovascular disease in obese individuals.
    • Understanding leptin resistance mechanisms is crucial for developing targeted therapies.
    • Novel strategies for treating obesity-associated CVD may emerge from insights into leptin's actions.